Company intelligence / Profile preview

Chongqing Harmony Pharmaceutical

Chongqing, Chongqing, Chinaen.sinopharm.com ↗

Ownership: Private
Development stage: Other

Overview

Chongqing Pharmaceutical (Group) Co., Ltd. ("CQP")—the likely intended entity—serves as a major pharmaceutical holding group in China with activities spanning pharmaceutical R&D, manufacturing of APIs/formulations/devices/biotech products, warehousing/logistics/distribution services for hospitals/pharmacies nationwide. It holds 19+ patents including those related to biotechnology and experimental cancer drugs. CQP reported annual revenue of $4.8 billion USD in 2019, maintains state-of-the-art GMP facilities exporting globally, and continues to expand through acquisitions such as Tasly Pharmaceuticals Inc.

Therapeutic areas: OncologyOther
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on Chongqing Harmony Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chongqing Harmony Pharmaceutical.

Explore the full profile